Kod-MD Tablet contains Ondansetron 4mg, a selective 5-HT3 receptor antagonist used primarily for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative conditions. Ondansetron exerts its antiemetic effect by blocking serotonin receptors located centrally in the chemoreceptor trigger zone and peripherally in the gastrointestinal tract, thereby inhibiting the initiation of the vomiting reflex. Kod-MD Tablet is indicated for adults and pediatric patients for the management of acute and delayed nausea and vomiting induced by cancer treatments and surgical procedures. The recommended dosage varies depending on the clinical scenario and patient age, with administration typically occurring prior to the emetogenic stimulus. Kod-MD is well tolerated, with common adverse effects including headache, constipation, and dizziness. It should be used with caution in patients with hepatic impairment and those with a history of cardiac arrhythmias, as ondansetron may prolong the QT interval. Kod-MD Tablet is contraindicated in patients with known hypersensitivity to ondansetron or any of its excipients. Careful assessment of drug interactions is advised, particularly with agents that affect cardiac conduction or cytochrome P450 enzymes. Kod-MD offers effective symptomatic relief from nausea and vomiting, improving patient comfort and compliance during therapeutic interventions.